Your browser doesn't support javascript.
loading
Prediction of significant prostate cancer in biopsy-naïve men: Validation of a novel risk model combining MRI and clinical parameters and comparison to an ERSPC risk calculator and PI-RADS.
Radtke, Jan Philipp; Giganti, Francesco; Wiesenfarth, Manuel; Stabile, Armando; Marenco, Jose; Orczyk, Clement; Kasivisvanathan, Veeru; Nyarangi-Dix, Joanne Nyaboe; Schütz, Viktoria; Dieffenbacher, Svenja; Görtz, Magdalena; Stenzinger, Albrecht; Roth, Wilfried; Freeman, Alex; Punwani, Shonit; Bonekamp, David; Schlemmer, Heinz-Peter; Hohenfellner, Markus; Emberton, Mark; Moore, Caroline M.
Affiliation
  • Radtke JP; Department of Urology, University Hospital Heidelberg, Heidelberg, Germany.
  • Giganti F; Department of Radiology, German Cancer Research Center, Heidelberg, Germany.
  • Wiesenfarth M; Department of Radiology, University College London Hospital NHS Foundation Trust, London, United Kingdom.
  • Stabile A; Division of Surgery & Interventional Science, University College London, London, United Kingdom.
  • Marenco J; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
  • Orczyk C; Division of Surgery & Interventional Science, University College London, London, United Kingdom.
  • Kasivisvanathan V; Department of Urology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Nyarangi-Dix JN; Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Schütz V; Vita-Salute San Raffaele University, Milan, Italy.
  • Dieffenbacher S; Department of Urology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Görtz M; Division of Surgery & Interventional Science, University College London, London, United Kingdom.
  • Stenzinger A; Department of Urology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Roth W; Division of Surgery & Interventional Science, University College London, London, United Kingdom.
  • Freeman A; Department of Urology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Punwani S; Department of Urology, University Hospital Heidelberg, Heidelberg, Germany.
  • Bonekamp D; Department of Urology, University Hospital Heidelberg, Heidelberg, Germany.
  • Schlemmer HP; Department of Urology, University Hospital Heidelberg, Heidelberg, Germany.
  • Hohenfellner M; Department of Radiology, German Cancer Research Center, Heidelberg, Germany.
  • Emberton M; Department of Urology, University Hospital Heidelberg, Heidelberg, Germany.
  • Moore CM; Institute of Pathology, University of Heidelberg, Heidelberg Germany.
PLoS One ; 14(8): e0221350, 2019.
Article in En | MEDLINE | ID: mdl-31450235
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostate / Prostatic Neoplasms / Magnetic Resonance Imaging / Early Detection of Cancer Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Aged / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostate / Prostatic Neoplasms / Magnetic Resonance Imaging / Early Detection of Cancer Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Aged / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2019 Type: Article